Given that MMPs inhibitors are not highly selective and did not impede a single MMPs function [55,56], it is tempting to speculate that targeting Tspan8 with antibodies might represent an alternative means to specifically block MMP-9 activity, and thereby deeper melanoma invasion of the dermis, the earliest stage before metastatic spreading. Here, MMP9 is linked to melanoma.